Vivimed Labs informs about outcome of board meeting

04 Jun 2022 Evaluate

Further to its letters dated 18.05.2022 & 30.05.2022, Vivimed Labs has informed that the Board of Directors of the Company at its meeting held on Friday, 3rd June, 2022 has approved the Audited Financial Results for the quarter and year ended 31 March, 2022. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the company enclosed the following: Statement of Audited Standalone Financial Results for the quarter and year ended 31 March, 2022 and Auditors' Report thereon, Statement of Audited Consolidated Financial Results for the quarter and year ended 31 March, 2022 and Auditors' Report thereon and Declaration regarding Audit Reports with unmodified opinion.

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

5.75 0.00 (0.00%)
31-Jul-2023 18:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1508.40
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.